2020-2021 Influenza Vaccination Recommendations and Clinical Guidance during the COVID-19 Pandemic
Posted about 5 years ago by Beth Malone
|
2020-2021 Influenza Vaccination Recommendations and Clinical Guidance during the COVID-19 Pandemic You may participate in this COCA Call via Zoom |
|
Advanced registration is not required. |
|
Overview |
|
During this COCA Call, presenters will discuss updates to the Advisory Committee on Immunization Practices (ACIP) recommendations for the 2020-2021 influenza vaccination season. Topics will include the Standards for Adult Immunization Practice, flu vaccination planning, general vaccination guidance during the COVID-19 pandemic, and guidance for large vaccination clinics held in satellite, temporary, or off-site locations.
If you are unable to attend the live COCA Call, the recording will be available for viewing on the COCA Call webpage a few hours after the live event ends.
The slide set will be available under "Call Materials" on the COCA Call webpage.
Free Continuing Education (CE) will be offered for this COCA Call. |
Date: Thursday, August 20, 2020
Time: 2:00pm-3:00pm (ET)
A few minutes before the webinar starts, please click on the Zoom link below to join: https://www.zoomgov.com/j/1601970527
Or iPhone one-tap : US: +16692545252,,1601970527# or +16468287666,,1601970527#
Or Telephone: Dial (for higher quality, dial a number based on your current location): US: +1 669 254 5252 or +1 646 828 7666
Webinar ID: 160 197 0527
International numbers available: https://www.zoomgov.com/u/aMN0chJG5 |
|
Activity-specific Objectives |
|
At the conclusion of the session, the participant will be able to accomplish the following—
|
|
COCA Call Objectives |
|
|
Presenters |
|
Lisa Grohskopf, MD, MPH, CAPT, USPHS Medical Officer, Influenza ACIP Lead Epidemiology and Prevention Branch, Influenza Division National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention
Tara Jatlaoui, MD, MPH, FACOG, LCDR, USPHS Co-Lead, Influenza Response Team Vaccine Planning Unit, Immunization Services Division National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention
Amy Parker Fiebelkorn, MSN, MPH, CAPT, USPHS Co-Lead, Influenza Response Team Vaccine Planning Unit, Immunization Services Division National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention |
|
Instructions for Obtaining Continuing Education |
|
To receive continuing education (CE) for WC2922-080420 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – 2020-2021 Influenza Vaccination Recommendations and Clinical Guidance during the COVID-19 Pandemic, Thursday, August 20, 2020, please visit TCEO and follow these 9 Simple Steps by Monday, September 21, 2020.
To receive continuing education (CE) for WD2922-080420 (Web on Demand) – Clinician Outreach and Communication Activity (COCA) Calls/Webinars - 2020-2021 Influenza Vaccination Recommendations and Clinical Guidance during the COVID-19 Pandemic, Thursday, August 20, 2020, please visit TCEO and follow these 9 Simple Steps by Thursday, September 22, 2022. |
|
Accreditation Statement |
|
CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity provides 1.0 contact hour.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.
CPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive) 0.1 CEUs in pharmacy education. The Universal Activity Number is JA4008229-0000-20-047-L04-P and enduring JA4008229-0000-20-048-H04-P course category.
This activity has been designated as Knowledge-Based.
Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.
For Certified Public Health Professionals (CPH) The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1.0 CPH recertification credit for this program.
AAVSB/RACE: This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education. Participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. Please contact the AAVSB RACE program at race@aavsb.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.
DISCLOSURE: In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias. Content will not include any discussion of the unlabeled use of a product or a product under investigational use, except Dr. Lisa Grohskopf’s discussion on the recommendations of the Advisory Committee on Immunization Practices (ACIP), where Dr. Grohskopf is the CDC Lead for the Influenza Work Group. The ACIP recommendations for persons with a history of severe allergic reaction to egg is a labeled contraindication for receipt of most influenza vaccines. However, ACIP recommends that persons with egg allergy of any severity should receive any licensed influenza vaccine appropriate for their age and health status. This will be explained during the presentation. CDC did not accept commercial support for this continuing education activity. |
||||||
|
The Emergency Risk Communication Branch in the Division of Emergency Operations, Center for Preparedness and Response is responsible for the management of all COCA products.
CDC and HHS logos are the exclusive property of the Department of Health and Human Services and may not be used for any purpose without prior express written permission. Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
|